👩⚕️PROFESSOR YINGFEN YING: A DISTINGUISHED MEDICAL PROFESSIONAL🌍
📘 EARLY ACADEMIC PURSUITS
Prof. Hao Peng’s academic journey began with graduate studies at Sun Yat-sen University Cancer Center, where he laid the groundwork for his expertise in oncology. Following this, he undertook postdoctoral research at the First Affiliated Hospital of Sun Yat-sen University. This period marked his immersion in groundbreaking research, fostering a deep interest in RNA epigenetic modifications and their role in cancer biology.
💼 PROFESSIONAL ENDEAVORS
Currently a Professor and Surgical Oncologist at Guangdong Provincial People’s Hospital in China, Prof. Peng combines clinical practice with impactful research. His dual roles allow him to contribute both to patient care and the academic community, exemplifying the integration of clinical insights into scientific discovery.
🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON RNA EPIGENETIC
Prof. Peng’s primary research interests revolve around RNA epigenetic modifications in cancer, particularly:
- tRNA m7G modification
- 18S rRNA m6A modification
- 28S rRNA m6A modification
He has elucidated how these modifications regulate mRNA translation and promote cancer progression. His findings have significantly enhanced the understanding of molecular mechanisms underlying oncogenesis.
🌍 IMPACT AND INFLUENCE
Prof. Peng has established himself as a thought leader in oncology, publishing several high-impact papers as the first and corresponding author in prestigious journals, including:
- Nature Metabolism
- Cell Reports
- Cell Chemical Biology
- Oncogene
These publications have contributed to advancing RNA epigenetics and its implications in cancer biology.
📊 ACADEMIC CITATIONS
With a growing citation impact, Prof. Peng’s research is widely referenced in the field, highlighting his influence on oncology research. His innovative work in RNA modifications has positioned him as a respected voice in his domain, shaping future studies in cancer therapeutics.
🔑 LEGACY AND FUTURE CONTRIBUTIONS
Prof. Peng has hosted multiple national research funds, emphasizing his role in advancing cancer research in China. His dedication to mentorship and collaboration ensures a lasting legacy in oncology. His ongoing research in RNA modifications holds promise for the development of novel therapeutic strategies, bridging the gap between molecular discoveries and clinical applications.
🏆 RECOGNITIONS AND LEADERSHIP
As a leader in the field, Prof. Peng continues to drive innovation in oncology. His contributions have earned him national recognition, solidifying his reputation as a pioneer in RNA epigenetics and its translational potential in cancer treatment.